主页文献库搜索
Nanoscale-Barrier Formation Induced by Low-Dose Electron-Beam Exposure in Ult...

Matsunaga(Masahiro),Higuchi(Ayaka),He(Guan... ACS Nano 0000-00-00

...MoS), may cause nanoscale structural modifications that in turn significantly modify the electrical operation of these d...

Impact of cognitive impairment, depression, disease activity, and disease dam...

Calderón(J),Flores(P),Aguirre(J M),Valdivi... Scand J Rheumatol 0000-00-00

...MOS) Short Form Health Survey version 2 (SF-12v2) to assess HRQoL and the Cambridge Neuropsychological Test Automated Ba...

Growing and Etching MoS₂ on Carbon Nanotube Film for Enhanced Electrochemical...

Xu(Weiyu),Fang(Qi),Liu(Daobin),Zhang(Ke),H... Molecules 0000-00-00

...MoS₂) nanosheets on carbon nanotube film (MoS₂@CNT) via a two-step chemical vapor deposition method (CVD). By etching th...

The role of brachytherapy in the treatment of glioblastoma multiforme.

Barbarite(Eric),Sick(Justin T),Berchmans(E... Neurosurg Rev 0000-00-00

...most recent search was performed in September 2015. Thirty-two series involving 1571 patients were included in our revie...

Meta-cognitive online sequential extreme learning machine for imbalanced and ...

Mirza(Bilal),Lin(Zhiping) Neural Netw 0000-00-00

...MOS-ELM) is proposed for class imbalance and concept drift learning. In MOS-ELM, meta-cognition is used to self-regulate...

Patient characteristics associated with the decision to undergo bilateral pro...

Muhsen(S),Junqueira(M J),Park(A),Sung(J S)... J Clin Oncol 0000-00-00

...mos), 120/944 (13%) patients in the surveillance +/- CP group developed breast cancer.,High-risk surveillance alone is t...

Impact of eribulin on overall survival in patients with metastatic breast can...

Vahdat(L T),Cortes(J),Twelves(C),Wanders(J... J Clin Oncol 0000-00-00

...mos) for eribulin-treated pts, with ORR=11.0% and CBR*=21.7% compared to OS=10.12 mos, ORR=5.0%, CBR*=16.6% for TPC-trea...

Expression (Exp) of FIP200 and Rb in breast cancer (BreastCA) metastasis (met...

Hashemi Sadraei(N),Burgett(M),Ahluwalia(M ... J Clin Oncol 0000-00-00

...mos), and median OS from Dx was 43 (range 6-264) mos. Nuclear Exp of Rb1 in < 30% vs. ≥ 30% of cells were seen in 11 vs....

Twelve versus 36 months of adjuvant imatinib (IM) as treatment of operable GI...

Joensuu(H),Eriksson(M),Hatrmann(J),Sundby ... J Clin Oncol 0000-00-00

...mos improves RFS and OS compared to 12 mos of administration as adjuvant treatment of GIST pts who have a high estimated...

Barriers in providing breast and colorectal cancer survivorship care: Percept...

Virgo(K S),Lerro(C C),Klabunde(C N),Earle(... J Clin Oncol 0000-00-00

...MOs perceive regarding breast and colorectal cancer survivorship care.,The Survey of Physician Attitudes Regarding the C...

上一页 697 698 699 700 701 702 703 704 下一页 701 / 共 704

联系地址

山东省济南市章丘区文博路2号

齐鲁师范学院 genelibs生信实验室

山东省济南市高新区舜华路750号

大学科技园北区F座4单元2楼

电话: 0531-88819269

微信公众号

关注微信订阅号,实时查看信息,关注医学生物学动态。


商务邮箱

E-mail: [email protected]